Financials
Financial year 2025
R.D.S. from Deerlijk, company number BE0431905762, closed financial year 2025 with a result of € 309,787 after tax. For that financial year R.D.S. recorded a gross margin of € 570,689 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 261,297 to € 309,787. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 1.4 million
▲ 27% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 309,787
▲ 19% vs 2024
Profit after tax over the fiscal year.
€ 513,062
▲ € 399,404 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.4 million.
People and assets in 2025
€ 217,406
▲ 124% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 667,844
▼ 1% vs 2024
€ 176,384 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 58,193
▲ € 51,655 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 109,147
▼ 51% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 441,140 | € 449,455 | € 530,251 | € 570,689 | ▲ 8% |
| Profit after taxes | € 199,868 | € 207,336 | € 261,297 | € 309,787 | ▲ 19% |
| Equity | € 848,422 | € 1,055,757 | € 1,127,055 | € 1,436,842 | ▲ 27% |
| Total debts | € 1,309,335 | € 1,138,655 | € 1,567,888 | € 1,298,027 | ▼ 17% |
| Cash | € 69,641 | € 100,385 | € 113,658 | € 513,062 | ▲ € 399,404 |
| Land & buildings | € 1,418,469 | € 1,323,465 | € 1,228,333 | € 1,201,361 | ▼ 2% |
| Retained profit | € 781,422 | € 988,757 | € 1,060,055 | € 1,369,842 | ▲ 29% |
| Dividend | € 0 | € 0 | € 190,000 | € 0 | ▼ 100% |
| Bank debt | € 1,102,835 | € 888,672 | € 678,006 | € 667,844 | ▼ 1% |
| Balance sheet total | € 2,193,643 | € 2,228,798 | € 2,727,828 | € 2,766,254 | ▲ 1% |
Key figures of R.D.S., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to R.D.S.?
What happened at R.D.S. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Steven Derez stepped down as director. NBB
- Charlotte Hellyn stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 309,787 (▲ 19% vs 2024). Source: NBB ↗
- Steven Derez became a director. NBB
- Charlotte Hellyn became a director. NBB
- New establishment in Deerlijk. KBO
- Start of the company according to the CBE. KBO
In short
From € 199,868 profit in 2022 to € 309,787 profit in 2025.
Paid € 427,768 in corporate taxes since 2022.
Best year ever: 2025, with € 309,787 profit.
Paid out € 190,000 in dividends to the owners in total.
Management
It owns 40% of DETA DS and 10.2% of PHARMANUTRICS itself.
Establishments
Establishment units
Physical locations of this company
Hoogstraat 103
8540 Deerlijk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0431.905.762
- VAT number
- BE 0431.905.762
- Registered office
- Hoogstraat 103, 8540 Deerlijk
- Names & denominations
- R.D.S.
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 September 1987
- Peppol
- Active · Active since 28 Aug 2023
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige zakelijke dienstverlening, neg